Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 17, 2020 - Issue 3
Submit an article Journal homepage
1,135
Views
1
CrossRef citations to date
0
Altmetric
Articles

COPD Positive Screening with Spirometry Increases Motivation to Quit Tobacco Smoking in an Addiction Treatment Center

Virgile Clergue-DuvalAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France; ;Faculté de Médecine, Université de Paris, Paris, France; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2803-8249
ORCID Icon,
Romain LairDépartement de Médecine Générale, Faculté de Médecine, Université Pierre et Marie Curie, Paris, France;
,
Camille Lefebvre-DurelAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France;
,
Thomas BarréAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France;
,
Marie-Astrid GautronAPHP, Unité de traitement ambulatoire des maladies addictives, Hôpital Beaujon, Clichy, France
,
Wajdi MehtelliAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France;
,
Frank BellivierAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France; ;Faculté de Médecine, Université de Paris, Paris, France; ORCID Iconhttp://orcid.org/0000-0002-3660-6640
ORCID Icon,
Frank QuestelAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France;
&
Florence VorspanAPHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand-Widal, Paris, France; ;Inserm UMRS-1144 Optimisation thérapeutique en neuropsychopharmacologie, Université de Paris, Paris, France; ;Faculté de Médecine, Université de Paris, Paris, France; ORCID Iconhttp://orcid.org/0000-0001-5168-3727
ORCID Icon show all
Pages 240-244 | Received 13 Jan 2020, Accepted 13 Apr 2020, Published online: 27 Apr 2020

References

  • Qaseem A. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179. doi:10.7326/0003-4819-155-3-201108020-00008.
  • Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016 [Internet]. Geneva: World Health Organization; 2018 [cited 2020 Apr 5]. Available from: www.who.int/healthinfo/global_burden_disease/estimates/en/
  • Rapsey CM, Lim CCW, Al-Hamzawi A, et al. Associations between DSM-IV mental disorders and subsequent COPD diagnosis. J Psychosom Res. 2015;79(5):333–339. doi:10.1016/j.jpsychores.2015.08.005.
  • Clair C, Mueller Y, Livingstone-Banks J, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2019;3:CD004705. doi:10.1002/14651858.CD004705.pub5.
  • Morris JF, Temple W. Spirometric “lung age” estimation for motivating smoking cessation. Prev Med. 1985;14(5):655–662. doi:10.1016/0091-7435(85)90085-4.
  • Alexander JA, Pollack H, Nahra T, et al. Case management and client access to health and social services in outpatient substance abuse treatment. J Behav Health Serv Res. 2007;34(3):221–236. doi:10.1007/s11414-007-9072-4.
  • Aubin H-J, Lagrue G, Legeron P, et al. Questionnaire de motivation à l’arrêt du tabac (Q-MAT). Alcool Addictol. 2004;26:311–316.
  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1(6077):1645–1648. doi:10.1136/bmj.1.6077.1645.
  • SPLF: Conditions de formation à la spirométrie [Spirometry training conditions] [Internet]. Paris: Société de Pneumologie de Langue Française. 2016. French; [cited 2020 Apr 5]. Available from: http://splf.fr/wp-content/uploads/2016/11/Conditions-formation-spiro-SPLF-FFP.pdf
  • MIR: Spirobank II [Internet]. Roma: Medical International Research; [cited 2020 Apr 5]. Available from: https://www.spirometry.com/Eng/Products/spirobank2.asp
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report) [Internet]. Fontana: Global initiative for chronic obstructive lung disease; 2020 [cited 2020 Apr 5]. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf
  • Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598–600. doi:10.1136/bmj.39503.582396.25.
  • Lipkus IM, Prokhorov AV. The effects of providing lung age and respiratory symptoms feedback on community college smokers’ perceived smoking-related health risks, worries and desire to quit. Addict Behav. 2007;32(3):516–532. doi:10.1016/j.addbeh.2006.05.018.
  • Kaminsky DA, Marcy T, Dorwaldt A, et al. Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept. Nicotine Tob Res. 2011;13(11):1161–1166. doi:10.1093/ntr/ntr096.
  • McBride CM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–170. doi:10.1093/her/18.2.156.
  • Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi:10.1186/1748-5908-6-42.
  • Quanjer PH, Enright P. Should we use “lung age”? Prim Care Respir J. 2010;19(3):197–199. doi:10.4104/pcrj.2010.00045.
  • Parkes G, Greenhalgh T. Paradoxes of spirometry results, and smoking cessation. Prim Care Respir J. 2010;19(3):295–296. doi:10.4104/pcrj.2010.00056.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.